Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0BI0Z
|
|||
Former ID |
DNC009863
|
|||
Drug Name |
4,4-Diphenyl-N-(pyridin-3-yl)-butyramide
|
|||
Synonyms |
CHEMBL565028; 4,4-Diphenyl-N-(pyridin-3-yl)-butyramide; SCHEMBL4617484; CEQRPUYSSDGEML-UHFFFAOYSA-N; BDBM50297404
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H20N2O
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C(CCC(=O)NC2=CN=CC=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C21H20N2O/c24-21(23-19-12-7-15-22-16-19)14-13-20(17-8-3-1-4-9-17)18-10-5-2-6-11-18/h1-12,15-16,20H,13-14H2,(H,23,24)
|
|||
InChIKey |
CEQRPUYSSDGEML-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Peroxisome | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Metapathway biotransformation | |||
Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J Med Chem. 2009 Oct 8;52(19):5880-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.